Skip to main content
Erschienen in: Pituitary 3/2012

01.09.2012

Cognitive function in acromegaly: description and brain volumetric correlates

verfasst von: Caroline Sievers, P. G. Sämann, H. Pfister, C. Dimopoulou, M. Czisch, J. Roemmler, J. Schopohl, G. K. Stalla, J. Zihl

Erschienen in: Pituitary | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

In acromegaly, we reported on increased rates of affective disorders such as dysthymia and depression, as well as structural brain changes. Objective of this study was to determine if cognitive impairments in patients with acromegaly exist and whether such impairments are associated with structural brain alterations defined by magnetic resonance imaging (MRI). In this cross-sectional study, 55 patients with biochemically confirmed acromegaly were enrolled. MRI data were compared with 87 control subjects. Main outcome measures were performance levels in 13 cognitive tests covering the domains of attention, memory and executive function, with performance below the cut-off level of the 16th percentile rated as impaired. In addition, individual global and hippocampal volume changes were defined for each patient in reference to a normative sample. We found that up to 33.3% of the patients were impaired in the attention, up to 24.1% in the memory, and up to 16.7% in the executive function domain. 67.3% of the patients failed to reach the cut-off level in at least one subtest. MRI demonstrated increased global, left and right hippocampal grey matter and white matter, particularly early in the disease course. Rather few positive than expected negative correlations could be established between the hippocampal grey matter gain and cognitive performance. Cognitive dysfunction, particularly attentional deficits, are common in acromegaly, rendering neuropsychological testing essential in the diagnostic work-up.
Literatur
1.
Zurück zum Zitat Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of DSMIV mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol (Oxf) 71:691–701CrossRef Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of DSMIV mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol (Oxf) 71:691–701CrossRef
2.
Zurück zum Zitat Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F (2009) Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm IGF Res 19:24–30PubMedCrossRef Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F (2009) Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm IGF Res 19:24–30PubMedCrossRef
3.
Zurück zum Zitat Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-Lopez P, Galvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 95:4367–4379PubMedCrossRef Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-Lopez P, Galvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 95:4367–4379PubMedCrossRef
4.
Zurück zum Zitat Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337–3341PubMedCrossRef Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337–3341PubMedCrossRef
5.
Zurück zum Zitat Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376PubMedCrossRef Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376PubMedCrossRef
6.
Zurück zum Zitat Carro E, Torres-Aleman I (2006) Serum insulin-like growth factor I in brain function. Keio J Med 55:59–63PubMedCrossRef Carro E, Torres-Aleman I (2006) Serum insulin-like growth factor I in brain function. Keio J Med 55:59–63PubMedCrossRef
7.
Zurück zum Zitat Carro E, Trejo JL, Fernandez S, Fernandez AM, Torres-Aleman I (2005) IGF-1 and neuroprotection. Academic Press, London Carro E, Trejo JL, Fernandez S, Fernandez AM, Torres-Aleman I (2005) IGF-1 and neuroprotection. Academic Press, London
8.
Zurück zum Zitat Clayton PE, Ayoola O, Whatmore AJ (2006) Patient selection for IGF-I therapy. Horm Res 65(Suppl 1):28–34PubMedCrossRef Clayton PE, Ayoola O, Whatmore AJ (2006) Patient selection for IGF-I therapy. Horm Res 65(Suppl 1):28–34PubMedCrossRef
9.
Zurück zum Zitat Sievers C, Schneider HJ, Stalla GK (2008) Insulin-like growth factor-1 in plasma and brain: regulation in health and disease. Front Biosci 13:85–99PubMedCrossRef Sievers C, Schneider HJ, Stalla GK (2008) Insulin-like growth factor-1 in plasma and brain: regulation in health and disease. Front Biosci 13:85–99PubMedCrossRef
10.
Zurück zum Zitat Aberg ND, Brywe KG, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 6:53–80CrossRef Aberg ND, Brywe KG, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 6:53–80CrossRef
11.
Zurück zum Zitat Le Greves M, Le Greves P, Nyberg F (2005) Age-related effects of IGF-1 on the NMDA-, GH- and IGF-1-receptor mRNA transcripts in the rat hippocampus. Brain Res Bull 65:369–374PubMedCrossRef Le Greves M, Le Greves P, Nyberg F (2005) Age-related effects of IGF-1 on the NMDA-, GH- and IGF-1-receptor mRNA transcripts in the rat hippocampus. Brain Res Bull 65:369–374PubMedCrossRef
12.
Zurück zum Zitat Arwert LI, Veltman DJ, Deijen JB, Lammertsma AA, Jonker C, Drent ML (2005) Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology 81:31–40PubMedCrossRef Arwert LI, Veltman DJ, Deijen JB, Lammertsma AA, Jonker C, Drent ML (2005) Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology 81:31–40PubMedCrossRef
13.
Zurück zum Zitat Arwert LI, Deijen JB, Drent ML (2005) The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm IGF Res 15:416–422PubMedCrossRef Arwert LI, Deijen JB, Drent ML (2005) The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm IGF Res 15:416–422PubMedCrossRef
14.
Zurück zum Zitat Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, Van der Veen EA, Koppeschaar HP (1999) Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 84:471–475PubMedCrossRef Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, Van der Veen EA, Koppeschaar HP (1999) Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 84:471–475PubMedCrossRef
15.
Zurück zum Zitat Aleman A, de Vries WR, de Haan EH, Verhaar HJ, Samson MM, Koppeschaar HP (2000) Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. Neuropsychobiology 41:73–78PubMedCrossRef Aleman A, de Vries WR, de Haan EH, Verhaar HJ, Samson MM, Koppeschaar HP (2000) Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. Neuropsychobiology 41:73–78PubMedCrossRef
16.
Zurück zum Zitat Sievers C, Sämann PG, Dose T, Dimopoulou C, Spieler D, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Czisch M, Pfister H, Stalla GK (2009) Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary 12:177–185PubMedCrossRef Sievers C, Sämann PG, Dose T, Dimopoulou C, Spieler D, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Czisch M, Pfister H, Stalla GK (2009) Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary 12:177–185PubMedCrossRef
17.
Zurück zum Zitat Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M (2007) Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol Psychiatry 62:400–406PubMedCrossRef Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M (2007) Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol Psychiatry 62:400–406PubMedCrossRef
18.
Zurück zum Zitat Whitmer RA (2007) Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7:373–380PubMedCrossRef Whitmer RA (2007) Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7:373–380PubMedCrossRef
19.
Zurück zum Zitat Shlyakhto E (2007) Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from >10,000 patients and review of the literature. Curr Med Res Opin 23(Suppl 5):S13–S18PubMedCrossRef Shlyakhto E (2007) Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from >10,000 patients and review of the literature. Curr Med Res Opin 23(Suppl 5):S13–S18PubMedCrossRef
20.
Zurück zum Zitat Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2009) Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 66:721–728PubMedCrossRef Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2009) Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 66:721–728PubMedCrossRef
21.
Zurück zum Zitat Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2010) Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression. Neuroimage 53:908–917PubMedCrossRef Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2010) Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression. Neuroimage 53:908–917PubMedCrossRef
22.
Zurück zum Zitat Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529PubMedCrossRef Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529PubMedCrossRef
23.
Zurück zum Zitat van der Lely AJ, Beckers A, Daly AF, Lamberts SWJ, Clemmons DR (2005) Acromegaly: pathology diagnosis and treatment. Taylor&Francis, Boca Raton van der Lely AJ, Beckers A, Daly AF, Lamberts SWJ, Clemmons DR (2005) Acromegaly: pathology diagnosis and treatment. Taylor&Francis, Boca Raton
24.
Zurück zum Zitat Zimmermann PF (1993) B: Testbatterie zur Aufmerksamkeitsprüfung (TAP) (Version 1.02c), Freiburg Zimmermann PF (1993) B: Testbatterie zur Aufmerksamkeitsprüfung (TAP) (Version 1.02c), Freiburg
25.
Zurück zum Zitat Brickenkamp R (2002) Test d2. Aufmerksamkeits-Belastungs-Test (9th revised version), Göttingen Brickenkamp R (2002) Test d2. Aufmerksamkeits-Belastungs-Test (9th revised version), Göttingen
26.
Zurück zum Zitat Gatterer G (1990) Alters-Konzentrationstest (AKT), Göttingen Gatterer G (1990) Alters-Konzentrationstest (AKT), Göttingen
27.
Zurück zum Zitat Wechsler D (2000) Wechsler-Gedächtnistest- Revidierte Fassung, Bern Wechsler D (2000) Wechsler-Gedächtnistest- Revidierte Fassung, Bern
28.
Zurück zum Zitat Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, Oxford Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, Oxford
29.
Zurück zum Zitat Helmstaedter C, Lendt M, Lux S (2001) VLMT—Verbaler Lern- und Merkfähigkeitstest, Göttingen Helmstaedter C, Lendt M, Lux S (2001) VLMT—Verbaler Lern- und Merkfähigkeitstest, Göttingen
30.
Zurück zum Zitat Raven J, Court J, Raven J Jr (1988) Standard progressive matrices. Weinheim, Beltz Test Gesellschaft Raven J, Court J, Raven J Jr (1988) Standard progressive matrices. Weinheim, Beltz Test Gesellschaft
31.
Zurück zum Zitat Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeitstest. Göttingen, Hogrefe Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeitstest. Göttingen, Hogrefe
32.
Zurück zum Zitat Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K (2005) A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25:1325–1335PubMedCrossRef Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K (2005) A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25:1325–1335PubMedCrossRef
33.
Zurück zum Zitat Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152PubMedCrossRef Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152PubMedCrossRef
34.
Zurück zum Zitat Etgen T, Bronner M, Sander D, Bickel H, Sander K, Forstl H (2009) Somatic factors in cognitive impairment. Fortschr Neurol Psychiatr 77:72–82PubMedCrossRef Etgen T, Bronner M, Sander D, Bickel H, Sander K, Forstl H (2009) Somatic factors in cognitive impairment. Fortschr Neurol Psychiatr 77:72–82PubMedCrossRef
Metadaten
Titel
Cognitive function in acromegaly: description and brain volumetric correlates
verfasst von
Caroline Sievers
P. G. Sämann
H. Pfister
C. Dimopoulou
M. Czisch
J. Roemmler
J. Schopohl
G. K. Stalla
J. Zihl
Publikationsdatum
01.09.2012
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 3/2012
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0326-z

Weitere Artikel der Ausgabe 3/2012

Pituitary 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.